Nucleoside reverse-transcriptase inhibitor dosing errors in an outpatient HIV clinic in the electronic medical record era
AuthorsWillig, James H.
Westfall, Andrew O.
Allison, Jeroan J.
Van Wagoner, Nicholas
Raper, James L
Saag, Michael S.
Mugavero, Michael J.
UMass Chan AffiliationsDepartment of Quantitative Health Sciences
Document TypeJournal Article
Internship and Residency
Kidney Failure, Chronic
Medical Records Systems, Computerized
Outpatient Clinics, Hospital
Practice Guidelines as Topic
Reverse Transcriptase Inhibitors
Health Services Research
MetadataShow full item record
AbstractInformation on antiretroviral dosing errors among health care providers for outpatient human immunodeficiency virus (HIV)-infected patients is lacking. We evaluated factors associated with nucleoside reverse-transcriptase inhibitor dosing errors in a university-based HIV clinic using an electronic medical record. Overall, older age, minority race or ethnicity, and didanosine use were related to such errors. Impaired renal function was more common in older patients and racial or ethnic minorities and, in conjunction with fixed-dose combination drugs, contributed to the higher rates of errors in nucleoside reverse-transcriptase inhibitor dosing. Understanding the factors related to nucleoside reverse-transcriptase inhibitor dosing errors is an important step in the building of preventive tools.
SourceClin Infect Dis. 2007 Sep 1;45(5):658-61. Epub 2007 Jul 13. Link to article on publisher's site
Permanent Link to this Itemhttp://hdl.handle.net/20.500.14038/47693
Related ResourcesLink to Article in PubMed
Rights© 2007 by the Infectious Diseases Society of America.